A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1

NCT00306631 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

CASI pharmaceuticals, Inc.